Drug diversion prevention and detection: Using a comprehensive risk and internal audit approach

Authored by Janice Ahlstrom

The estimated cost of controlled prescription drug diversion and abuse to both public and private medical insurers is approximately $72.5 billion a year.1 Now consider that approximately 10 to 15 percent of all healthcare professionals will misuse drugs or alcohol at some time during their career.2 Healthcare organizations face serious legal, financial, operational and reputational risks and regulatory fines resulting from worker drug diversion and inadequate internal controls. To effectively address these issues, a comprehensive interdisciplinary drug diversion management program must include rigorous controls and monitoring.

Take a deeper dive into this important topic affecting the healthcare industry and understand the common points of risk, best practices to developing a management program and how a risk-based internal audit approach serves as an effective solution for remediation and ongoing monitoring.

Download our guide to managing drug diversion at your organization >

For more information on this topic, or to learn how Baker Tilly healthcare specialists can help, contact our team.

1 The High Cost of Drug Diversion.  Pharmacy Times, January 3, 2016. http://www.pharmacytimes.com/contributor/erica-lindsay-pharmd-mba-jd/2016/01/the-high-cost-of-drug-diversion

2 MR Baldisserri, Impaired Healthcare Professional. Critical Care Medicine. 2007; 35(2 suppl):S106-16.